MAT Tools and Resources

The Opioid Prevention Campaign is a public health media campaign to help prevent adolescent substance use. The stress and uncertainty that surrounds COVID-19 has resulted in a rise in drug and alcohol use. Take action today to prevent opioid use disorder among teens and adolescents.

This Opioid Prevention Campaign toolkit translates the science of prevention into simple strategies parents and caregivers can incorporate into busy daily lives -- to do what we can to protect our kids from developing an addiction later in life.

Language matters when it comes to treating substance use disorders (SUD). Stigma has been proven to have a negative impact on health outcomes, not only leading many individuals with SUD to not seek treatment, but also influencing how health professionals treat their patients. Using non-stigmatizing, person-centered, and recovery-oriented language can help providers facilitate engagement in treatment for individuals with SUD.

This resource provides practical information about a variety of approaches to prevent addiction-related stigma. Some are especially simple and can be initiated by individuals on their own. These include tips on using stigma-free language and writing letters to the editor. Some approaches are comprehensive, such as developing a community action group and implementing a community-based campaign.

Provider Bridge is a platform that will streamline the process for mobilizing health care professionals during the COVID-19 pandemic and future public health emergencies. Utilizing communications pathways and new technology, Provider Bridge will make it easier to connect health care professionals with state agencies and health care entities in order to quickly increase access to care for patients via telehealth.

The Centers for Medicare and Medicaid Services is responding to the opioid epidemic by promoting safe and responsible pain management, making sure patients can access treatment for opioid use disorder, and using data to target prevention and treatment.

The Commonwealth Fund, the Center for Care Innovations, and the University of California, San Francisco have launched this toolkit to support providers in using telemedicine to care for vulnerable patients during this challenging time, and as means of advancing health equity.

These clinical tools include guidance and forms for the implementation of medication-assisted treatment in ambulatory care settings.

Starting January 1, 2020, under the Calendar Year (CY) 2020 Physician Fee Schedule final rule the Centers for Medicare & Medicaid Services will pay Opioid Treatment Programs through bundled payments for opioid use disorder treatment services in an episode of care provided to people with Medicare Part B (Medical Insurance).

In the Calender Year 2020 Physician Fee Schedule final rule, the Centers for Medicare and Medicaid Services included new coding and payment for a monthly bundle of services for the treatment of opioid use disorder that includes overall management, care coordination, individual and group psychotherapy, substance use counseling, and add-on code for additional counseling. This is a way for clinicians to bill for a group of services in the office setting similar to the services covered under the Opioid Treatment Program benefit for clinics.